Skip to content

Direct Meds review

By Marcus HaleLongevity Research Editor
Updated

Unusually straight on price and states — and under an FDA letter

It publishes the monthly figure, what that figure includes, the two states it cannot serve, and a promise that the price does not rise with your dose. It also received an FDA warning letter in September 2025.

FDA warning letter. The FDA issued a warning letter to directmeds.com, Inc. dba DirectMeds in September 2025. You can look it up on the FDA’s warning-letter index.

We may earn a commission if you sign up through our links, at no cost to you. How we make money.

Key details

Advertised price
The hero reads "Starting at $147", beneath a site-wide banner reading "Summer Discount Applied! SAVE $150 instantly". The pricing FAQ gives the standing rates: "For Semaglutide we charge $297/month. For Tirzepatide we charge $399/month."
Billing details
$297/month for compounded semaglutide and $399/month for compounded tirzepatide, month to month with no contract. Both include the medication, the doctor visits (which the company itself prices at $99 a visit), 1-day FedEx or UPS shipping and all injection supplies. "Subscribe and save" discounts exist in exchange for committing to a plan length; those figures are not published.
Pharmacy
Not named individually, but the category is stated and that is the more useful half of the answer: "Pharmacies are US based 503A compounding pharmacies", with an explanation that they operate under state pharmacy-board licensure, federal compounding law and USP 795/797 standards. Direct Meds also says it has its own medical director, a practicing physician who has reviewed its prescriber and pharmacy network — though that person is not named. It states in its own words that compounded medications "are not FDA-approved". The corporate entity behind DirectMeds is the one named on the FDA warning letter.
Availability
The current FAQ excludes Mississippi and Louisiana. Confirm current program eligibility for your address; the seller’s statement is a service restriction, not independent legal guidance about either state.
Review coverage
Separate review. Not ranked as an NAD+ provider and not eligible to be: Direct Meds sells no NAD+ product at all. It is a compounded-GLP-1 weight-loss telehealth, shown only in the clearly labeled GLP-1 section of our NAD+-for-weight-loss page, where the point is that NAD+ does not cause weight loss and GLP-1 medications do. It is reviewed here because it is operating under an FDA warning letter that belongs in front of anyone about to click.

Our verdict

Two things are true here at once, and both belong up front. In September 2025 the FDA issued a warning letter to the corporate entity doing business as DirectMeds — the company whose site you reach from this page. The other is that Direct Meds is unusually open about price. Its pricing FAQ states flat monthly figures — $297 for compounded semaglutide, $399 for compounded tirzepatide — and itemizes what they include: the medication, the telemed visits it values at $99 each, 1-day courier shipping, and all injection supplies. It promises "same price, every dose", names 503A compounding pharmacies as its category, and publishes a state-exclusion list instead of hiding eligibility behind a quiz. The catch is the headline: "Starting at $147" is $297 minus the "$150 instantly" banner running at the top of the same page.

NAD+ evidence

The route question we normally ask does not apply here: Direct Meds sells no NAD+, so there is no NAD+ delivery route to assess. GLP-1 receptor agonists are exactly what NAD+ therapy is not — a drug class with large randomized controlled trials behind hard weight endpoints. The usual qualifier applies: those trials tested FDA-approved branded products, and what is sold here is compounded semaglutide and tirzepatide, which inherit the molecule but not the trial data. Direct Meds states the compounding part itself. What it does not qualify is its marketing, which promises "the proven way to lose 15% of your body weight fast", "lose 1-2lbs per week", and a slider estimating a visitor "could easily lose 44 lbs" — trial-shaped numbers presented without the trial, the dose, or the adherence conditions attached to them.

Pricing and fees

Advertised price
The hero reads "Starting at $147", beneath a site-wide banner reading "Summer Discount Applied! SAVE $150 instantly". The pricing FAQ gives the standing rates: "For Semaglutide we charge $297/month. For Tirzepatide we charge $399/month."
Payment terms
$297/month for compounded semaglutide and $399/month for compounded tirzepatide, month to month with no contract. Both include the medication, the doctor visits (which the company itself prices at $99 a visit), 1-day FedEx or UPS shipping and all injection supplies. "Subscribe and save" discounts exist in exchange for committing to a plan length; those figures are not published.
Pricing details
The $147 headline is $297 minus the $150 promotion. The expanded FAQ states $297/month semaglutide and $399/month tirzepatide. Confirm the actual checkout discount and next charge; other sale badges do not establish a different standing rate.

Additional fees

  • Medication, medical visits, injection supplies and shipping included in the published standing price
  • Terms describe 30-day subscription charges and advance notice 5–7 days before billing
  • Turn off auto-refill at least 48 hours before the next processing date
  • Attempted prescription cancellation within 24 hours depends on the provider network not having received the order; pharmacy and fulfillment exceptions apply

Prices are from Direct Meds's own website and can change without notice.

Who it may suit

May suit you if

  • You have weighed the FDA warning letter and decided that is a risk you are prepared to carry
  • You want one flat monthly number that already contains the visit, the supplies and the shipping rather than a base price with fees stacked underneath
  • You want a written promise that titrating up will not raise your bill — Direct Meds makes that promise
  • You want to know whether your state is served before you start, not after a quiz

Consider another option if

  • You want a provider with no open FDA action attached to it — a sufficient reason on its own, and this category has alternatives
  • You live in Mississippi or Louisiana, which it states plainly it cannot serve
  • You want to complete the medical intake before being charged — here the money comes first
  • You want NAD+ — Direct Meds sells none, and nothing on this site ranks it as an NAD+ provider

What’s included

Consultation
Yes, and priced openly: the telemed visits sit inside the monthly figure, which the pricing FAQ notes would "normally" be $99 a visit. The sequence puts payment first — you buy, then complete the medical intake in the patient portal, and a practitioner is expected to review the chart within 24 hours and often under five. A prescription that is not approved is fully refunded.
Lab testing
Not mentioned anywhere on the page or its FAQ. No bloodwork step is described in either direction.
Follow-up care
Included and concretely described: when you run out you message the doctor in the patient portal, who reviews the dosage, adjusts it if needed and writes a new prescription for next-day delivery. Crucially the site states the price does not change with the dose.
Clinical support
The page describes a nursing team, clinician portal messaging and phone/email support. The terms allow auto-refill cancellation through the account at least 48 hours before processing.
Supplies
Included: "all supplies needed for injections" sit inside the monthly price.
Shipping
The page advertises included next-day courier shipping after processing; medical review and pharmacy handling occur before transit. Confirm the actual dispatch estimate rather than treating the hero delivery claim as a guarantee.

Limitations and policy details

The FDA issued a warning letter to the corporate entity doing business as DirectMeds in September 2025, and it sits on the agency's public record under that name. We won't characterize the agency's case: the letter is published, it is one click away, and its existence and date are what you need before handing over a payment and a medical history. One tip if you look it up: the FDA database files it under the run-together name "directmeds", so a search for "direct meds" with a space can miss it. Separately, the $147 headline is promotional rather than the standing $297 semaglutide price, and payment precedes the medical intake. “Cancel anytime” needs the terms beside it: auto-refill must be stopped 48 hours before processing, while an individual prescription may already be too far along to cancel within the first 24 hours.

Other considerations

  • An FDA warning letter issued in September 2025 to the corporate entity doing business as DirectMeds, the company behind Direct Meds' site, is on the public record
  • The "Starting at $147" headline is the $297 semaglutide rate minus the $150 promotion banner running on the same page
  • Auto-refill cancellation needs 48 hours before processing
  • Payment comes before the detailed medical intake; the FAQ promises a refund if not approved
  • The actual dispensing pharmacy is not named for the order

Cost calculators

How this site makes money

We may earn a commission when you buy a product or start care through our links, at no extra cost to you. Affiliate partners appear first in our provider comparison. Read the full disclosure.

View Direct Meds

Every figure on this page comes from Direct Meds’s own site, and prices change without notice. Read every provider review.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.